|
It was reported a patient underwent a robotic cholecystectomy procedure on (b)(6) 2026 and topical skin adhesive was used.The patient developed a rash with red, raised bumps around the trocar port sites.The patient was treated with benadryl, hydrocortisone cream, and kenalog cream applied twice daily for 7 to 10 days.No additional patient outcome information was provided.Device is not available for return.Additional information has been requested.
|
|
Product complaint # (b)(4).Additional information: d4: udi: as the lot number for the device involved in the event was not provided, the full udi is currently not available.Additional information has been requested however not received.Attempts to obtain the device have been made.If further details are received at a later date a supplemental medwatch will be sent.What was the procedure date.May 21? what date /day post op was the reaction noted, may 21? was any surgical intervention performed? when was the dermabond product removed from the patient? were any cultures taken? results? please describe how was the adhesive was applied.What prep was used prior to, during or after adhesive use? how was the wound cleaned and dried prior to prineo application? was a dressing placed over the incision? if so, what type of cover dressing used? is the patient hypersensitive or have allergies to cyanoacrylate or formaldehyde? is the patient hypersensitive to pressure sensitive adhesives? does the patient have allergies to medication, food, etc.? was patient screening done prior the procedure, e.G.Check patient not allergic to cyanoacrylate, formaldehyde, bac, pressure-sensitive adhesive? patient demographics: initials / id, gender, age or date of birth; bmi.Patient pre-existing medical conditions (ie.Allergies, history of reactions).Has the patient used or been exposed to similar glues/agents for repair, crafts, cosmetic use (lashes, nails)? was prineo/dermabond or skin adhesive used on the patient in a previous surgery or wound closure? product lot of product used? current patient status.What is the physician¿s opinion as to the etiology of or contributing factors to this event? no product is available for return.This report is being submitted pursuant to the provisions of 21 cfr, part 803.This report may be based on information which has not been investigated or verified prior to the required reporting date.This report does not reflect a conclusion by ethicon, or its employees that the report constitutes an admission that the product, ethicon, or its employees caused or contributed to the potential event described in this report.If information is obtained that was not available for the initial report, a follow-up report will be filed as appropriate.
|